We addressed this problem by applying high-throughput in vitro nutrient screening and found that under glucose-restricted conditions and KRAS–MAPK signalling activation, uridine serves as a nutrient source for PDA cells. The gene discussed is KRAS; the disease is Patent ductus arteriosus.